This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

J.P. Morgan Reaffirms Their Buy Rating on Xylem (XYL)

Tipranks - Tipranks - Sat May 2, 7:40AM CDT

In a report released yesterday, Michael Fairbanks from J.P. Morgan maintained a Buy rating on Xylem, with a price target of $140.00. The company’s shares closed yesterday at $118.16.

Claim 55% Off TipRanks

According to TipRanks, Fairbanks is an analyst with an average return of -8.9% and a 44.44% success rate.

In addition to J.P. Morgan, Xylem also received a Buy from Citi’s Andrew Kaplowitz in a report issued on April 29. However, on the same day, UBS assigned a Hold rating to Xylem (NYSE: XYL).

See Insiders’ Hot Stocks on TipRanks >>

Based on Xylem’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $2.13 billion and a net profit of $185 million. In comparison, last year the company earned a revenue of $2.07 billion and had a net profit of $169 million

Read More on XYL:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).